U.S. market Closed. Opens in 6 hours 2 minutes

PETQ | PetIQ, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 30.98 - 30.98
52 Week Range 15.09 - 31.06
Beta 1.81
Implied Volatility 101.50%
IV Rank 3.18%
Day's Volume N/A
Average Volume 923,497
Shares Outstanding 29,669,800
Market Cap 919,170,404
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 2017-07-21
Valuation
Profitability
Growth
Health
P/E Ratio 83.73
Forward P/E Ratio N/A
EPS 0.37
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 1,121
Country USA
Website PETQ
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
PETQ's peers: BHC, EBS, ZTS, HLN
*Chart delayed
Analyzing fundamentals for PETQ we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is very bad and Health is passable. For more detailed analysis please see PETQ Fundamentals page.

Watching at PETQ technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on PETQ Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙